375 related articles for article (PubMed ID: 23566883)
1. Synthesis and 18F-labeling of the analogues of Omecamtiv Mecarbil as a potential cardiac myosin imaging agent with PET.
Zhang M; Mou T; Zhao Z; Peng C; Ma Y; Fang W; Zhang X
Nucl Med Biol; 2013 Jul; 40(5):689-96. PubMed ID: 23566883
[TBL] [Abstract][Full Text] [Related]
2. Preparation and biodistribution of [18F]FP2OP as myocardial perfusion imaging agent for positron emission tomography.
Mou T; Jing H; Yang W; Fang W; Peng C; Guo F; Zhang X; Pang Y; Ma Y
Bioorg Med Chem; 2010 Feb; 18(3):1312-20. PubMed ID: 20056551
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.
Mou T; Zhao Z; Fang W; Peng C; Guo F; Liu B; Ma Y; Zhang X
J Nucl Med; 2012 Mar; 53(3):472-9. PubMed ID: 22302832
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[(18) F]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET.
Mou T; Zhao Z; You L; Wang Q; Fang W; Lu J; Peng C; Zhang X
J Labelled Comp Radiopharm; 2015 Jun; 58(8):349-54. PubMed ID: 26094722
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of [18F]-labeled (2-(2-fluoroethoxy)ethyl)tris(4-methoxyphenyl)phosphonium cation as a potential agent for positron emission tomography myocardial imaging.
Kim DY; Kim HJ; Yu KH; Min JJ
Nucl Med Biol; 2012 Oct; 39(7):1093-8. PubMed ID: 22575270
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
[TBL] [Abstract][Full Text] [Related]
8. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
Wu Z; Li L; Liu S; Yakushijin F; Yakushijin K; Horne D; Conti PS; Li Z; Kandeel F; Shively JE
J Nucl Med; 2014 Jul; 55(7):1178-84. PubMed ID: 24854793
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ¹⁸F-labeled BODIPY dye as potential PET agents for myocardial perfusion imaging.
Liu S; Li D; Shan H; Gabbaï FP; Li Z; Conti PS
Nucl Med Biol; 2014 Jan; 41(1):120-6. PubMed ID: 24210284
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of (18)F-labeled Pyridaben Analogues for Myocardial Perfusion Imaging in Mice, Rats and Chinese mini-swine.
Mou T; Zhao Z; You L; Li Y; Wang Q; Fang W; Lu J; Peng C; Zhang X
Sci Rep; 2016 Sep; 6():33450. PubMed ID: 27646847
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.
Hausner SH; Bauer N; Sutcliffe JL
Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053
[TBL] [Abstract][Full Text] [Related]
12. Novel
Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
[TBL] [Abstract][Full Text] [Related]
13. Highly efficient one-pot labeling of new phosphonium cations with fluorine-18 as potential PET agents for myocardial perfusion imaging.
Zhao Z; Yu Q; Mou T; Liu C; Yang W; Fang W; Peng C; Lu J; Liu Y; Zhang X
Mol Pharm; 2014 Nov; 11(11):3823-31. PubMed ID: 24852080
[TBL] [Abstract][Full Text] [Related]
14.
Gao F; Peng C; Zhuang R; Guo Z; Liu H; Huang L; Li H; Xu D; Wen X; Fang J; Zhang X
Nucl Med Biol; 2019; 72-73():62-69. PubMed ID: 31330414
[TBL] [Abstract][Full Text] [Related]
15. 18F-Fluorosulfate for PET Imaging of the Sodium-Iodide Symporter: Synthesis and Biologic Evaluation In Vitro and In Vivo.
Khoshnevisan A; Chuamsaamarkkee K; Boudjemeline M; Jackson A; Smith GE; Gee AD; Fruhwirth GO; Blower PJ
J Nucl Med; 2017 Jan; 58(1):156-161. PubMed ID: 27539841
[TBL] [Abstract][Full Text] [Related]
16. Perspectives of a myosin motor activator agent with increased selectivity.
Nánási P; Komáromi I; Almássy J
Can J Physiol Pharmacol; 2018 Jul; 96(7):676-680. PubMed ID: 29792814
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging.
Liu Z; Pourghiasian M; Bénard F; Pan J; Lin KS; Perrin DM
J Nucl Med; 2014 Sep; 55(9):1499-505. PubMed ID: 24970911
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive PET Imaging of CDK4/6 Activation in Breast Cancer.
Ramos N; Baquero-Buitrago J; Ben Youss Gironda Z; Wadghiri YZ; Reiner T; Boada FE; Carlucci G
J Nucl Med; 2020 Mar; 61(3):437-442. PubMed ID: 31481582
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of [¹¹C]PBR06 and [¹⁸F]PBR06 as agents for positron emission tomographic (PET) imaging of the translocator protein (TSPO).
Wang M; Gao M; Miller KD; Zheng QH
Steroids; 2011 Nov; 76(12):1331-40. PubMed ID: 21756927
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
